NANO MOBILE HEALTHCARE, INC. Nano Mobile Healthcare, Inc. Share Price
Equities
VNTH
US63010B2007
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0003 USD | 0.00% |
|
0.00% | 0.00% |
| 02/01 | Nano Mobile Healthcare, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
| 2023 | Nano Mobile Healthcare, Inc. Announces Executive Changes | CI |
| Sales 2021 | - | Sales 2022 | - | Capitalization | 9L 7.36Cr |
|---|---|---|---|---|---|
| Net income 2021 | - 0 | Net income 2022 | - 0 | EV / Sales 2021 | - |
| Net cash position 2021 * | - 0 | Net Debt 2022 | 0.51 42.35 | EV / Sales 2022 | - |
| P/E ratio 2021 * |
-
| P/E ratio 2022 |
-
| Employees | 18 |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 87.18% |
More Fundamentals
* Assessed data
More news
More press releases
1 week
0.00
0.00
1 month
0.000.00
Current year
0.000.00
1 year
0.000.00
3 years
0.000.01
5 years
0.000.01
10 years
0.003.00
| Managers | Title | Age | Since |
|---|---|---|---|
Roy Watson
CEO | Chief Executive Officer | - | 11/23/11 |
Robert Chicoski
BRD | Director/Board Member | 81 | 30/17/30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
James Katzaroff
BRD | Director/Board Member | 66 | 31/17/31 |
Robert Chicoski
BRD | Director/Board Member | 81 | 30/17/30 |
Roy Watson
CEO | Chief Executive Officer | - | 11/23/11 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/24/24 | 0.0003 | 0.00% | 4,209,011 |
| 21/24/21 | 0.0003 | 0.00% | 9,344 |
| 20/24/20 | 0.0003 | 0.00% | 283,432 |
| 18/24/18 | 0.0003 | 0.00% | 286,011 |
Delayed Quote OTC Markets, June 25, 2024 at 12:42 am IST
More quotes
Nano Mobile Healthcare, Inc. develops small, hand-held screening devices, which utilize nanotechnology to detect the presence of specific compounds in the breath. The Companyâs first products are the convergence of nano-electronics, bio-informatics, and wireless technology. The products are based on patented technology invented by the National Aeronautics and Space Administration (NASA), which is license to Nanobeak, and further sub-licensed to the Company. The Company is focused on its screening for the presence of disease or the use of drugs.
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 10L | |
| -4.16% | 18TCr | |
| -2.39% | 10TCr | |
| -4.08% | 6.82TCr | |
| +16.04% | 4.71TCr | |
| -11.10% | 4.4TCr | |
| +6.35% | 4.09TCr | |
| +17.63% | 3.11TCr | |
| -8.10% | 2.41TCr | |
| +11.06% | 2.41TCr |
- Stock Market
- Equities
- VNTH Stock
